_id
691b09573c536f8df23189af
Ticker
ALDVI.PA
Name
Advicenne
Exchange
PA
Address
3Eme Etage, Paris, France, 75008
Country
France
Sector
Healthcare
Industry
Biotechnology
Currency
EUR
Website
https://www.advicenne.com
Description
Advicenne S.A., a specialty pharmaceutical company, develops, commercializes, and markets treatments for rare renal diseases in France and internationally. The company offers Sibnayal for the treatment of metabolic disorders, distal renal tubular acidosis, and cystinuria. It also distributes Likozam, a formulation of clobazam for the treatment of short-term symptomatic of severe, disabling, or condition-causing anxiety unacceptable distress; and Levidcen, a galenic form of levetiracetam for the treatment of epileptic seizures. Advicenne S.A. was incorporated in 2007 and is headquartered in Paris, France.
Last Close
1.76
Volume
7628
Current Price
1.814
Change
-2.7272727272727297
Last Updated
2025-12-30T12:35:50.225Z
Image
https://logo.clearbit.com/www.advicenne.com
Ipo Date
-
Market Cap
25610710
Next Dividend Date
-
Dividend Frequency
-
Dividend Rate
-
Dividend Yield
0
Sentiment
-
Sentiment Sources
0
Rating
4.5
Strong Buy
1
Buy
1
Hold
0
Sell
0
Strong Sell
0
Current Quarter
2025-06-30
Revenue
3266000
Cost Of Revenue
3689000
Gross Profit
-423000
Operating Expenses
3953000
Operating Income
-4376000
Interest Expense
683000
Pretax Income
-5058000
Net Income
-4957000
Eps
-0.40223404211293856
Dividends Per Share
-
Shares Outstanding
14551540
Income Tax Expense
101000
EBITDA
-3109500
Operating Margin
-133.98652786282915
Total Other Income Expense Net
-682000
Cash
515000
Short Term Investments
-
Receivables
3344000
Inventories
1427000
Total Current Assets
6100000
Property Plant Equipment
132000
Total Assets
6730000
Payables
1629000
Short Term Debt
-
Long Term Debt
18672000
Total Liabilities
30735000
Equity
-24005000
Bs_currency_symbol
EUR
Depreciation
1266500
Change In Working Capital
-
Cash From Operations
-
Capital Expenditures
0
Cash From Investing
-
Cash From Financing
-
Net Change In Cash
-
Cf_currency_symbol
-
PE
-
PB
-0.9312701184753177
ROE
20.64986461153926
ROA
-73.6552748885587
FCF
-
Fcf Percent
-
Piotroski FScore
0
Health Score
38
Deep Value Investing Score
0.5
Defensive Investing Score
7
Dividend Investing Score
1.5
Economic Moat Investing Score
5.3
Garp Investing Score
2.5
Growth Investing Score
2
Momentum Investing Score
2
Net Net Investing Score
0.5
Quality Investing Score
2
Value Investing Score
4
Quarters > 0 > quarter
2025-06-30
Quarters > 0 > income Statement > revenue
3266000
Quarters > 0 > income Statement > cost Of Revenue
3689000
Quarters > 0 > income Statement > gross Profit
-423000
Quarters > 0 > income Statement > operating Expenses
3953000
Quarters > 0 > income Statement > operating Income
-4376000
Quarters > 0 > income Statement > interest Expense
683000
Quarters > 0 > income Statement > pretax Income
-5058000
Quarters > 0 > income Statement > net Income
-4957000
Quarters > 0 > income Statement > eps
-0.40223404211293856
Quarters > 0 > income Statement > dividends Per Share
-
Quarters > 0 > income Statement > shares Outstanding
12323671
Quarters > 0 > income Statement > income Tax Expense
101000
Quarters > 0 > income Statement > EBITDA
-3109500
Quarters > 0 > income Statement > operating Margin
-133.98652786282915
Quarters > 0 > income Statement > total Other Income Expense Net
-682000
Quarters > 0 > income Statement > currency_symbol
-
Quarters > 0 > balance Sheet > cash
515000
Quarters > 0 > balance Sheet > short Term Investments
-
Quarters > 0 > balance Sheet > receivables
3344000
Quarters > 0 > balance Sheet > inventories
1427000
Quarters > 0 > balance Sheet > total Current Assets
6100000
Quarters > 0 > balance Sheet > property Plant Equipment
132000
Quarters > 0 > balance Sheet > total Assets
6730000
Quarters > 0 > balance Sheet > payables
1629000
Quarters > 0 > balance Sheet > short Term Debt
-
Quarters > 0 > balance Sheet > long Term Debt
18672000
Quarters > 0 > balance Sheet > total Liabilities
30735000
Quarters > 0 > balance Sheet > equity
-24005000
Quarters > 0 > balance Sheet > currency_symbol
EUR
Quarters > 0 > cash Flow > net Income
-4957000
Quarters > 0 > cash Flow > depreciation
1266500
Quarters > 0 > cash Flow > change In Working Capital
-
Quarters > 0 > cash Flow > cash From Operations
-
Quarters > 0 > cash Flow > capital Expenditures
0
Quarters > 0 > cash Flow > cash From Investing
-
Quarters > 0 > cash Flow > cash From Financing
-
Quarters > 0 > cash Flow > net Change In Cash
-
Quarters > 0 > cash Flow > currency_symbol
-
Quarters > 0 > ratios > PE
-0.40223404211293856
Quarters > 0 > ratios > PB
-0.9312701184753177
Quarters > 0 > ratios > ROE
20.64986461153926
Quarters > 0 > ratios > ROA
-73.6552748885587
Quarters > 0 > ratios > FCF
-
Quarters > 0 > ratios > Piotroski FScore
0
Quarters > 0 > ratios > fcf Percent
-
Quarters > 0 > health Score
38
Quarters > 1 > quarter
2024-12-31
Quarters > 1 > income Statement > revenue
3315000
Quarters > 1 > income Statement > cost Of Revenue
5082000
Quarters > 1 > income Statement > gross Profit
-1878000
Quarters > 1 > income Statement > operating Expenses
6524000
Quarters > 1 > income Statement > operating Income
-4874000
Quarters > 1 > income Statement > interest Expense
402000
Quarters > 1 > income Statement > pretax Income
-1295000
Quarters > 1 > income Statement > net Income
-931000
Quarters > 1 > income Statement > eps
-0.0794999988045113
Quarters > 1 > income Statement > dividends Per Share
-
Quarters > 1 > income Statement > shares Outstanding
11710692
Quarters > 1 > income Statement > income Tax Expense
-229000
Quarters > 1 > income Statement > EBITDA
5978000
Quarters > 1 > income Statement > operating Margin
-147.02865761689293
Quarters > 1 > income Statement > total Other Income Expense Net
3579000
Quarters > 1 > income Statement > currency_symbol
-
Quarters > 1 > balance Sheet > cash
3248000
Quarters > 1 > balance Sheet > short Term Investments
-
Quarters > 1 > balance Sheet > receivables
3734000
Quarters > 1 > balance Sheet > inventories
1682000
Quarters > 1 > balance Sheet > total Current Assets
8806000
Quarters > 1 > balance Sheet > property Plant Equipment
227000
Quarters > 1 > balance Sheet > total Assets
9507000
Quarters > 1 > balance Sheet > payables
2031000
Quarters > 1 > balance Sheet > short Term Debt
-
Quarters > 1 > balance Sheet > long Term Debt
18187000
Quarters > 1 > balance Sheet > total Liabilities
28580000
Quarters > 1 > balance Sheet > equity
-19073000
Quarters > 1 > balance Sheet > currency_symbol
EUR
Quarters > 1 > cash Flow > net Income
-931000
Quarters > 1 > cash Flow > depreciation
901000
Quarters > 1 > cash Flow > change In Working Capital
1782000
Quarters > 1 > cash Flow > cash From Operations
1885000
Quarters > 1 > cash Flow > capital Expenditures
56000
Quarters > 1 > cash Flow > cash From Investing
-73000
Quarters > 1 > cash Flow > cash From Financing
-532000
Quarters > 1 > cash Flow > net Change In Cash
1280000
Quarters > 1 > cash Flow > currency_symbol
-
Quarters > 1 > ratios > PE
-0.0794999988045113
Quarters > 1 > ratios > PB
-1.1137836359251299
Quarters > 1 > ratios > ROE
4.881245740051381
Quarters > 1 > ratios > ROA
-9.79278426422636
Quarters > 1 > ratios > FCF
1829000
Quarters > 1 > ratios > Piotroski FScore
2
Quarters > 1 > ratios > fcf Percent
0.5517345399698341
Quarters > 1 > health Score
38
Quarters > 2 > quarter
2024-06-30
Quarters > 2 > income Statement > revenue
1658000
Quarters > 2 > income Statement > cost Of Revenue
1067000
Quarters > 2 > income Statement > gross Profit
-342000
Quarters > 2 > income Statement > operating Expenses
5381000
Quarters > 2 > income Statement > operating Income
-4935000
Quarters > 2 > income Statement > interest Expense
881000
Quarters > 2 > income Statement > pretax Income
-5676000
Quarters > 2 > income Statement > net Income
-5533000
Quarters > 2 > income Statement > eps
-0.450466329941796
Quarters > 2 > income Statement > dividends Per Share
-
Quarters > 2 > income Statement > shares Outstanding
12282827
Quarters > 2 > income Statement > income Tax Expense
-143000
Quarters > 2 > income Statement > EBITDA
-3195000
Quarters > 2 > income Statement > operating Margin
-297.6477683956574
Quarters > 2 > income Statement > total Other Income Expense Net
-741000
Quarters > 2 > income Statement > currency_symbol
EUR
Quarters > 2 > balance Sheet > cash
1968000
Quarters > 2 > balance Sheet > short Term Investments
-
Quarters > 2 > balance Sheet > receivables
1848000
Quarters > 2 > balance Sheet > inventories
1722000
Quarters > 2 > balance Sheet > total Current Assets
6460000
Quarters > 2 > balance Sheet > property Plant Equipment
1151000
Quarters > 2 > balance Sheet > total Assets
7969000
Quarters > 2 > balance Sheet > payables
1316000
Quarters > 2 > balance Sheet > short Term Debt
11355000
Quarters > 2 > balance Sheet > long Term Debt
6175000
Quarters > 2 > balance Sheet > total Liabilities
25386000
Quarters > 2 > balance Sheet > equity
-17417000
Quarters > 2 > balance Sheet > currency_symbol
EUR
Quarters > 2 > cash Flow > net Income
-5533000
Quarters > 2 > cash Flow > depreciation
1636000
Quarters > 2 > cash Flow > change In Working Capital
-480000
Quarters > 2 > cash Flow > cash From Operations
-2647000
Quarters > 2 > cash Flow > capital Expenditures
35000
Quarters > 2 > cash Flow > cash From Investing
-35000
Quarters > 2 > cash Flow > cash From Financing
-600000
Quarters > 2 > cash Flow > net Change In Cash
-3282000
Quarters > 2 > cash Flow > currency_symbol
EUR
Quarters > 2 > ratios > PE
-0.450466329941796
Quarters > 2 > ratios > PB
-1.2792701485904576
Quarters > 2 > ratios > ROE
31.767813056209448
Quarters > 2 > ratios > ROA
-69.43154724557661
Quarters > 2 > ratios > FCF
-2682000
Quarters > 2 > ratios > Piotroski FScore
1
Quarters > 2 > ratios > fcf Percent
-1.6176115802171291
Quarters > 2 > health Score
31
Quarters > 3 > quarter
2024-03-31
Quarters > 3 > income Statement > revenue
884500
Quarters > 3 > income Statement > cost Of Revenue
533500
Quarters > 3 > income Statement > gross Profit
351000
Quarters > 3 > income Statement > operating Expenses
2690500
Quarters > 3 > income Statement > operating Income
-2339500
Quarters > 3 > income Statement > interest Expense
-
Quarters > 3 > income Statement > pretax Income
-2769500
Quarters > 3 > income Statement > net Income
-2766500
Quarters > 3 > income Statement > eps
-0.225233164970898
Quarters > 3 > income Statement > dividends Per Share
-
Quarters > 3 > income Statement > shares Outstanding
12282827
Quarters > 3 > income Statement > income Tax Expense
3000
Quarters > 3 > income Statement > EBITDA
-1597500
Quarters > 3 > income Statement > operating Margin
-264.4997173544375
Quarters > 3 > income Statement > total Other Income Expense Net
-430000
Quarters > 3 > income Statement > currency_symbol
-
Quarters > 3 > balance Sheet > cash
1968000
Quarters > 3 > balance Sheet > short Term Investments
-
Quarters > 3 > balance Sheet > receivables
1848000
Quarters > 3 > balance Sheet > inventories
1722000
Quarters > 3 > balance Sheet > total Current Assets
6460000
Quarters > 3 > balance Sheet > property Plant Equipment
1151000
Quarters > 3 > balance Sheet > total Assets
7969000
Quarters > 3 > balance Sheet > payables
1316000
Quarters > 3 > balance Sheet > short Term Debt
11355000
Quarters > 3 > balance Sheet > long Term Debt
-
Quarters > 3 > balance Sheet > total Liabilities
25386000
Quarters > 3 > balance Sheet > equity
-17417000
Quarters > 3 > balance Sheet > currency_symbol
-
Quarters > 3 > cash Flow > net Income
-2766500
Quarters > 3 > cash Flow > depreciation
826500
Quarters > 3 > cash Flow > change In Working Capital
-240000
Quarters > 3 > cash Flow > cash From Operations
-1323500
Quarters > 3 > cash Flow > capital Expenditures
17500
Quarters > 3 > cash Flow > cash From Investing
-
Quarters > 3 > cash Flow > cash From Financing
-300000
Quarters > 3 > cash Flow > net Change In Cash
-1641000
Quarters > 3 > cash Flow > currency_symbol
-
Quarters > 3 > ratios > PE
-0.225233164970898
Quarters > 3 > ratios > PB
-1.2792701485904576
Quarters > 3 > ratios > ROE
15.883906528104724
Quarters > 3 > ratios > ROA
-34.715773622788305
Quarters > 3 > ratios > FCF
-1341000
Quarters > 3 > ratios > Piotroski FScore
1
Quarters > 3 > ratios > fcf Percent
-1.5161107970604861
Quarters > 3 > health Score
28
Annuals > 0 > quarter
2024-12-31
Annuals > 0 > income Statement > revenue
4973000
Annuals > 0 > income Statement > cost Of Revenue
6149000
Annuals > 0 > income Statement > gross Profit
-1176000
Annuals > 0 > income Statement > operating Expenses
2416000
Annuals > 0 > income Statement > operating Income
-9059000
Annuals > 0 > income Statement > interest Expense
1283000
Annuals > 0 > income Statement > pretax Income
-10325000
Annuals > 0 > income Statement > net Income
-6464000
Annuals > 0 > income Statement > eps
-0.5300000180383669
Annuals > 0 > income Statement > dividends Per Share
-
Annuals > 0 > income Statement > shares Outstanding
12196226
Annuals > 0 > income Statement > income Tax Expense
-372000
Annuals > 0 > income Statement > EBITDA
1300000
Annuals > 0 > income Statement > operating Margin
-182.16368389302232
Annuals > 0 > income Statement > total Other Income Expense Net
-1268000
Annuals > 0 > income Statement > currency_symbol
EUR
Annuals > 0 > balance Sheet > cash
3248000
Annuals > 0 > balance Sheet > short Term Investments
-
Annuals > 0 > balance Sheet > receivables
3734000
Annuals > 0 > balance Sheet > inventories
1682000
Annuals > 0 > balance Sheet > total Current Assets
8806000
Annuals > 0 > balance Sheet > property Plant Equipment
227000
Annuals > 0 > balance Sheet > total Assets
9507000
Annuals > 0 > balance Sheet > payables
2031000
Annuals > 0 > balance Sheet > short Term Debt
730
Annuals > 0 > balance Sheet > long Term Debt
18187000
Annuals > 0 > balance Sheet > total Liabilities
28580000
Annuals > 0 > balance Sheet > equity
-19073000
Annuals > 0 > balance Sheet > currency_symbol
EUR
Annuals > 0 > cash Flow > net Income
-6464000
Annuals > 0 > cash Flow > depreciation
2584000
Annuals > 0 > cash Flow > change In Working Capital
2209000
Annuals > 0 > cash Flow > cash From Operations
-762000
Annuals > 0 > cash Flow > capital Expenditures
91000
Annuals > 0 > cash Flow > cash From Investing
-108000
Annuals > 0 > cash Flow > cash From Financing
-1132000
Annuals > 0 > cash Flow > net Change In Cash
-2003000
Annuals > 0 > cash Flow > currency_symbol
EUR
Annuals > 0 > ratios > PE
-0.5300000180383669
Annuals > 0 > ratios > PB
-1.098574753211346
Annuals > 0 > ratios > ROE
33.89084045509359
Annuals > 0 > ratios > ROA
-67.99200589039654
Annuals > 0 > ratios > FCF
-853000
Annuals > 0 > ratios > Piotroski FScore
1
Annuals > 0 > ratios > fcf Percent
-0.1715262417052081
Annuals > 0 > health Score
31
Annuals > 1 > quarter
2023-12-31
Annuals > 1 > income Statement > revenue
4458000
Annuals > 1 > income Statement > cost Of Revenue
6676000
Annuals > 1 > income Statement > gross Profit
-6308000
Annuals > 1 > income Statement > operating Expenses
4255000
Annuals > 1 > income Statement > operating Income
-6457000
Annuals > 1 > income Statement > interest Expense
577000
Annuals > 1 > income Statement > pretax Income
-7032000
Annuals > 1 > income Statement > net Income
-7031000
Annuals > 1 > income Statement > eps
-0.6703738247005343
Annuals > 1 > income Statement > dividends Per Share
-
Annuals > 1 > income Statement > shares Outstanding
10488178
Annuals > 1 > income Statement > income Tax Expense
-1000
Annuals > 1 > income Statement > EBITDA
-6244000
Annuals > 1 > income Statement > operating Margin
-144.84073575594437
Annuals > 1 > income Statement > total Other Income Expense Net
-575000
Annuals > 1 > income Statement > currency_symbol
EUR
Annuals > 1 > balance Sheet > cash
5250000
Annuals > 1 > balance Sheet > short Term Investments
-
Annuals > 1 > balance Sheet > receivables
3107000
Annuals > 1 > balance Sheet > inventories
1741000
Annuals > 1 > balance Sheet > total Current Assets
9262000
Annuals > 1 > balance Sheet > property Plant Equipment
2776000
Annuals > 1 > balance Sheet > total Assets
12407000
Annuals > 1 > balance Sheet > payables
1045000
Annuals > 1 > balance Sheet > short Term Debt
1420000
Annuals > 1 > balance Sheet > long Term Debt
15886000
Annuals > 1 > balance Sheet > total Liabilities
24377000
Annuals > 1 > balance Sheet > equity
-11970000
Annuals > 1 > balance Sheet > currency_symbol
EUR
Annuals > 1 > cash Flow > net Income
-7031000
Annuals > 1 > cash Flow > depreciation
211000
Annuals > 1 > cash Flow > change In Working Capital
341000
Annuals > 1 > cash Flow > cash From Operations
-5989000
Annuals > 1 > cash Flow > capital Expenditures
1282000
Annuals > 1 > cash Flow > cash From Investing
-1318000
Annuals > 1 > cash Flow > cash From Financing
4233000
Annuals > 1 > cash Flow > net Change In Cash
-3072000
Annuals > 1 > cash Flow > currency_symbol
EUR
Annuals > 1 > ratios > PE
-0.6703738247005343
Annuals > 1 > ratios > PB
-1.5053207856307436
Annuals > 1 > ratios > ROE
58.73851294903927
Annuals > 1 > ratios > ROA
-56.66962198758765
Annuals > 1 > ratios > FCF
-7271000
Annuals > 1 > ratios > Piotroski FScore
0
Annuals > 1 > ratios > fcf Percent
-1.6310004486316734
Annuals > 1 > health Score
30
Annuals > 2 > quarter
2022-12-31
Annuals > 2 > income Statement > revenue
2397000
Annuals > 2 > income Statement > cost Of Revenue
1117000
Annuals > 2 > income Statement > gross Profit
1280000
Annuals > 2 > income Statement > operating Expenses
11339000
Annuals > 2 > income Statement > operating Income
-10059000
Annuals > 2 > income Statement > interest Expense
1373000
Annuals > 2 > income Statement > pretax Income
-11433000
Annuals > 2 > income Statement > net Income
-11471000
Annuals > 2 > income Statement > eps
-1.1346333297526754
Annuals > 2 > income Statement > dividends Per Share
5000000
Annuals > 2 > income Statement > shares Outstanding
10109874
Annuals > 2 > income Statement > income Tax Expense
37000
Annuals > 2 > income Statement > EBITDA
-9871000
Annuals > 2 > income Statement > operating Margin
-419.64956195244054
Annuals > 2 > income Statement > total Other Income Expense Net
-1374000
Annuals > 2 > income Statement > currency_symbol
EUR
Annuals > 2 > balance Sheet > cash
8322000
Annuals > 2 > balance Sheet > short Term Investments
2000
Annuals > 2 > balance Sheet > receivables
2383000
Annuals > 2 > balance Sheet > inventories
982000
Annuals > 2 > balance Sheet > total Current Assets
12083000
Annuals > 2 > balance Sheet > property Plant Equipment
1906000
Annuals > 2 > balance Sheet > total Assets
14259000
Annuals > 2 > balance Sheet > payables
1122000
Annuals > 2 > balance Sheet > short Term Debt
1416000
Annuals > 2 > balance Sheet > long Term Debt
16746000
Annuals > 2 > balance Sheet > total Liabilities
24875000
Annuals > 2 > balance Sheet > equity
-10498000
Annuals > 2 > balance Sheet > currency_symbol
EUR
Annuals > 2 > cash Flow > net Income
-11470000
Annuals > 2 > cash Flow > depreciation
334000
Annuals > 2 > cash Flow > change In Working Capital
288000
Annuals > 2 > cash Flow > cash From Operations
-9147000
Annuals > 2 > cash Flow > capital Expenditures
115000
Annuals > 2 > cash Flow > cash From Investing
-2000
Annuals > 2 > cash Flow > cash From Financing
4783000
Annuals > 2 > cash Flow > net Change In Cash
-4363000
Annuals > 2 > cash Flow > currency_symbol
EUR
Annuals > 2 > ratios > PE
-1.1346333297526754
Annuals > 2 > ratios > PB
-1.6544830950657266
Annuals > 2 > ratios > ROE
109.26843208230139
Annuals > 2 > ratios > ROA
-80.44743670664141
Annuals > 2 > ratios > FCF
-9262000
Annuals > 2 > ratios > Piotroski FScore
1
Annuals > 2 > ratios > fcf Percent
-3.863996662494785
Annuals > 2 > health Score
31
Annuals > 3 > quarter
2021-12-31
Annuals > 3 > income Statement > revenue
2689000
Annuals > 3 > income Statement > cost Of Revenue
973000
Annuals > 3 > income Statement > gross Profit
1716000
Annuals > 3 > income Statement > operating Expenses
14159000
Annuals > 3 > income Statement > operating Income
-12443000
Annuals > 3 > income Statement > interest Expense
1248000
Annuals > 3 > income Statement > pretax Income
-12438000
Annuals > 3 > income Statement > net Income
-12427000
Annuals > 3 > income Statement > eps
-1.3154543604977957
Annuals > 3 > income Statement > dividends Per Share
56000
Annuals > 3 > income Statement > shares Outstanding
9446926
Annuals > 3 > income Statement > income Tax Expense
-11000
Annuals > 3 > income Statement > EBITDA
-12036000
Annuals > 3 > income Statement > operating Margin
-462.73707698029006
Annuals > 3 > income Statement > total Other Income Expense Net
6000
Annuals > 3 > income Statement > currency_symbol
EUR
Annuals > 3 > balance Sheet > cash
12685000
Annuals > 3 > balance Sheet > short Term Investments
-
Annuals > 3 > balance Sheet > receivables
802000
Annuals > 3 > balance Sheet > inventories
717000
Annuals > 3 > balance Sheet > total Current Assets
16616000
Annuals > 3 > balance Sheet > property Plant Equipment
1835000
Annuals > 3 > balance Sheet > total Assets
18881000
Annuals > 3 > balance Sheet > payables
2929000
Annuals > 3 > balance Sheet > short Term Debt
165000
Annuals > 3 > balance Sheet > long Term Debt
12003000
Annuals > 3 > balance Sheet > total Liabilities
18572000
Annuals > 3 > balance Sheet > equity
309000
Annuals > 3 > balance Sheet > currency_symbol
EUR
Annuals > 3 > cash Flow > net Income
-12427000
Annuals > 3 > cash Flow > depreciation
426000
Annuals > 3 > cash Flow > change In Working Capital
-743000
Annuals > 3 > cash Flow > cash From Operations
-12525000
Annuals > 3 > cash Flow > capital Expenditures
297000
Annuals > 3 > cash Flow > cash From Investing
-395000
Annuals > 3 > cash Flow > cash From Financing
8853000
Annuals > 3 > cash Flow > net Change In Cash
-4086000
Annuals > 3 > cash Flow > currency_symbol
EUR
Annuals > 3 > ratios > PE
-1.3154543604977957
Annuals > 3 > ratios > PB
52.52368565695792
Annuals > 3 > ratios > ROE
-4021.6828478964403
Annuals > 3 > ratios > ROA
-65.81748848048302
Annuals > 3 > ratios > FCF
-12822000
Annuals > 3 > ratios > Piotroski FScore
1
Annuals > 3 > ratios > fcf Percent
-4.768315358869468
Annuals > 3 > health Score
9
Valuation > metrics > PE
-0.40223404211293856
Valuation > metrics > PB
-0.9312701184753177
Valuation > final Score
50
Valuation > verdict
Fair
Profitability > metrics > ROE
20.64986461153926
Profitability > metrics > ROA
-81.26229508196722
Profitability > metrics > Net Margin
-1.5177587262706675
Profitability > final Score
40
Profitability > verdict
Weak
Risk > metrics > Interest Coverage
-6.407027818448023
Risk > final Score
4
Risk > verdict
High
Liquidity > metrics > Current Ratio
3.7446286065070598
Liquidity > metrics > Quick Ratio
2.868631062001228
Liquidity > final Score
100
Liquidity > verdict
Great
Prev Valuations > 0
50
Prev Valuations > 1
50
Prev Valuations > 2
50
Prev Profitabilities > 0
10
Prev Profitabilities > 1
40
Prev Profitabilities > 2
32
Prev Risks > 0
-18
Prev Risks > 1
8
Prev Risks > 2
22
Prev Liquidities > 0
100
Prev Liquidities > 1
29
Prev Liquidities > 2
29
Updated At
2026-01-20T23:08:37.860Z
Earnings History > 0 > period
2025-06-30
Earnings History > 0 > report Date
2025-09-20
Earnings History > 0 > date
2025-06-30
Earnings History > 0 > before After Market
-
Earnings History > 0 > currency
-
Earnings History > 0 > eps Actual
-0.4
Earnings History > 0 > eps Estimate
0
Earnings History > 0 > eps Difference
-0.4
Earnings History > 0 > surprise Percent
-
Earnings History > 1 > period
2025-03-31
Earnings History > 1 > report Date
2025-04-29
Earnings History > 1 > date
2025-03-31
Earnings History > 1 > before After Market
-
Earnings History > 1 > currency
-
Earnings History > 1 > eps Actual
-0.36
Earnings History > 1 > eps Estimate
0
Earnings History > 1 > eps Difference
-0.36
Earnings History > 1 > surprise Percent
-
Earnings History > 2 > period
2024-06-30
Earnings History > 2 > report Date
2024-09-18
Earnings History > 2 > date
2024-06-30
Earnings History > 2 > before After Market
-
Earnings History > 2 > currency
-
Earnings History > 2 > eps Actual
-0.45
Earnings History > 2 > eps Estimate
0
Earnings History > 2 > eps Difference
-0.45
Earnings History > 2 > surprise Percent
-
Earnings History > 3 > period
2022-12-31
Earnings History > 3 > report Date
2023-03-30
Earnings History > 3 > date
2022-12-31
Earnings History > 3 > before After Market
AfterMarket
Earnings History > 3 > currency
EUR
Earnings History > 3 > eps Actual
-1.16
Earnings History > 3 > eps Estimate
-
Earnings History > 3 > eps Difference
0
Earnings History > 3 > surprise Percent
-
Earnings History > 4 > period
2022-06-30
Earnings History > 4 > report Date
2022-09-21
Earnings History > 4 > date
2022-06-30
Earnings History > 4 > before After Market
AfterMarket
Earnings History > 4 > currency
EUR
Earnings History > 4 > eps Actual
-0.48
Earnings History > 4 > eps Estimate
-
Earnings History > 4 > eps Difference
0
Earnings History > 4 > surprise Percent
-
Earnings History > 5 > period
2021-12-31
Earnings History > 5 > report Date
2022-03-31
Earnings History > 5 > date
2021-12-31
Earnings History > 5 > before After Market
AfterMarket
Earnings History > 5 > currency
EUR
Earnings History > 5 > eps Actual
-1.34
Earnings History > 5 > eps Estimate
0
Earnings History > 5 > eps Difference
-1.34
Earnings History > 5 > surprise Percent
-
Earnings History > 6 > period
2021-06-30
Earnings History > 6 > report Date
2021-09-29
Earnings History > 6 > date
2021-06-30
Earnings History > 6 > before After Market
BeforeMarket
Earnings History > 6 > currency
EUR
Earnings History > 6 > eps Actual
-0.93
Earnings History > 6 > eps Estimate
0
Earnings History > 6 > eps Difference
-0.93
Earnings History > 6 > surprise Percent
-
Earnings History > 7 > period
2021-03-31
Earnings History > 7 > report Date
2021-04-28
Earnings History > 7 > date
2021-03-31
Earnings History > 7 > before After Market
AfterMarket
Earnings History > 7 > currency
EUR
Earnings History > 7 > eps Actual
-0.84
Earnings History > 7 > eps Estimate
0
Earnings History > 7 > eps Difference
-0.84
Earnings History > 7 > surprise Percent
-
Earnings History > 8 > period
2020-06-30
Earnings History > 8 > report Date
2020-09-25
Earnings History > 8 > date
2020-06-30
Earnings History > 8 > before After Market
BeforeMarket
Earnings History > 8 > currency
EUR
Earnings History > 8 > eps Actual
-0.92
Earnings History > 8 > eps Estimate
0
Earnings History > 8 > eps Difference
-0.92
Earnings History > 8 > surprise Percent
-
Earnings History > 9 > period
2019-12-31
Earnings History > 9 > report Date
2020-03-13
Earnings History > 9 > date
2019-12-31
Earnings History > 9 > before After Market
BeforeMarket
Earnings History > 9 > currency
EUR
Earnings History > 9 > eps Actual
-0.89
Earnings History > 9 > eps Estimate
0
Earnings History > 9 > eps Difference
-0.89
Earnings History > 9 > surprise Percent
-
Earnings History > 10 > period
2019-09-30
Earnings History > 10 > report Date
2019-10-01
Earnings History > 10 > date
2019-09-30
Earnings History > 10 > before After Market
-
Earnings History > 10 > currency
EUR
Earnings History > 10 > eps Actual
-0.85
Earnings History > 10 > eps Estimate
0
Earnings History > 10 > eps Difference
-0.85
Earnings History > 10 > surprise Percent
-
Earnings History > 11 > period
2019-03-31
Earnings History > 11 > report Date
2019-05-02
Earnings History > 11 > date
2019-03-31
Earnings History > 11 > before After Market
-
Earnings History > 11 > currency
EUR
Earnings History > 11 > eps Actual
-0.16
Earnings History > 11 > eps Estimate
0
Earnings History > 11 > eps Difference
-0.16
Earnings History > 11 > surprise Percent
-
Earnings History > 12 > period
2018-06-30
Earnings History > 12 > report Date
2018-09-20
Earnings History > 12 > date
2018-06-30
Earnings History > 12 > before After Market
AfterMarket
Earnings History > 12 > currency
EUR
Earnings History > 12 > eps Actual
-0.47
Earnings History > 12 > eps Estimate
0
Earnings History > 12 > eps Difference
-0.47
Earnings History > 12 > surprise Percent
-
Earnings History > 13 > period
2018-03-31
Earnings History > 13 > report Date
2018-04-10
Earnings History > 13 > date
2018-03-31
Earnings History > 13 > before After Market
AfterMarket
Earnings History > 13 > currency
EUR
Earnings History > 13 > eps Actual
-0.39
Earnings History > 13 > eps Estimate
0
Earnings History > 13 > eps Difference
-0.39
Earnings History > 13 > surprise Percent
-
Earnings History > 14 > period
2017-09-30
Earnings History > 14 > report Date
2017-11-22
Earnings History > 14 > date
2017-09-30
Earnings History > 14 > before After Market
BeforeMarket
Earnings History > 14 > currency
EUR
Earnings History > 14 > eps Actual
-0.37
Earnings History > 14 > eps Estimate
0
Earnings History > 14 > eps Difference
-0.37
Earnings History > 14 > surprise Percent
-
Earnings History > 15 > period
2016-12-31
Earnings History > 15 > report Date
2017-02-03
Earnings History > 15 > date
2016-12-31
Earnings History > 15 > before After Market
-
Earnings History > 15 > currency
EUR
Earnings History > 15 > eps Actual
-0.27
Earnings History > 15 > eps Estimate
0
Earnings History > 15 > eps Difference
-0.27
Earnings History > 15 > surprise Percent
-
Earnings History > 16 > period
2016-06-30
Earnings History > 16 > report Date
2016-08-04
Earnings History > 16 > date
2016-06-30
Earnings History > 16 > before After Market
-
Earnings History > 16 > currency
EUR
Earnings History > 16 > eps Actual
-0.29
Earnings History > 16 > eps Estimate
0
Earnings History > 16 > eps Difference
-0.29
Earnings History > 16 > surprise Percent
-
Advicenne S.A., a specialty pharmaceutical company, develops, commercializes, and markets treatments for rare renal diseases in France and internationally. The company offers Sibnayal for the treatment of metabolic disorders, distal renal tubular acidosis, and cystinuria. It also distributes Likozam, a formulation of clobazam for the treatment of short-term symptomatic of severe, disabling, or condition-causing anxiety unacceptable distress; and Levidcen, a galenic form of levetiracetam for the treatment of epileptic seizures. Advicenne S.A. was incorporated in 2007 and is headquartered in Paris, France.
Stock Price
€0.00
decrease compared to yesterday.
Dividend
Frequency:
Rate:
N/ANext Payout:
N/A(Last Updated 2025-06-30)
Rating:
STRONG BUY
$
Analyst Picks
Strong Buy
1
Buy
1
Hold
0
Sell
0
Strong Sell
0
(Last Updated 2025-06-30)
Health Score
Price to Book Ratio (P/B)
-
Very Low
Low ≤ 1
High ≥ 3
Return on Equity (ROE)
-
High
Low ≤ 5%
High ≥ 25%
Return on Assets (ROA)
-
Very Low
Low ≤ 2%
High ≥ 10%
* Institutions hold a combined 0.00% of the total shares of Advicenne
* Investors data is estimated based on stocks listed on Finnton that are currently held by Institution/Fund.
Date
—
EPS Estimate
—
Date
2025-06-30
EPS Actual
-0.4
EPS Estimate
0
EPS Difference
-0.4
Surprise Percent
0%
(Last Updated 2025-06-30)
(Last Updated 2025-06-30)
Revenue
€ 0
Cost Of Revenue
€ 0
Gross Profit
€ 0
Operating Expenses
€ 0
Operating Income
€ 0
Interest Expense
€ 0
Pretax Income
€ 0
Net Income
€ 0
Income Tax Expense
€ 0
EBITDA
€ 0
Total Other Income Expense Net
€ 0
Earnings Per Share
0
Dividends Per Share
0
Shares Outstanding
0
Operating Margin
0%
(Last Updated 2025-06-30)
Cash
€ 0
Short Term Investments
€ 0
Receivables
€ 0
Inventories
€ 0
Total Current Assets
€ 0
Property Plant Equipment
€ 0
Total Assets
€ 0
Payables
€ 0
Short Term Debt
€ 0
Long Term Debt
€ 0
Total Liabilities
€ 0
Equity
€ 0
(Last Updated 2025-06-30)
Net Income
€ 0
Depreciation
€ 0
Change In Working Capital
€ 0
Cash From Operations
€ 0
Capital Expenditures
€ 0
Cash From Investing
€ 0
Cash From Financing
€ 0
Net Change In Cash
€ 0
Disclaimer: Finnton is a stock screener tool provided for informational and educational purposes only. The data, analysis, and insights offered on this website do not constitute financial, investment, tax, or legal advice. Users are solely responsible for their own investment decisions, and Finnton makes no guarantees regarding the accuracy, completeness, or reliability of the information provided. Past performance is not indicative of future results. Always conduct your own research and consult with a licensed financial advisor before making any investment decisions.